BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

nVerses Capital, LLC's Holding History (CIK: 0002011399)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024

Shares 15,500 Value ($000) $118 Avg Close $7.60 Range $6.17 - $8.88

Q2 2024

Shares 10,200 Value ($000) $63 Avg Close $5.52 Range $4.03 - $6.99

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2024	15,500	$118	$7.60	$6.17 - $8.88
Q2 2024	10,200	$63	$5.52	$4.03 - $6.99